Skip to main content
. Author manuscript; available in PMC: 2013 Aug 1.
Published in final edited form as: Invest New Drugs. 2011 Sep 1;30(4):1575–1584. doi: 10.1007/s10637-011-9732-3

Table 4.

Pharmacokinetics of dasatinib

Dose level Date N Cmax (ng/mL) AUC(0-T) (ng.h/mL) Tmax (h) T-HALF (h)

Geomean (%CV) Geomean (%CV) Med (Min, Max) Mean (SD)
100 mg Day 0 3 101.0 (40.5) 475.9 (61.3) 1.0 (0.5, 4.0) 6.8 (0.1)
Day 15 3 165.5 (73.4) 663.6 (65.1) 0.5 (0.5, 5.0) 6.4 (0.1)
150 mg Day 0 18 144.0 (58.5) 594.0 (45.3) 1.5 (0.5, 4.0) 5.2 (1.0)
Day 15 18 145 (77.4) 621.2 (52.9) 2.0 (0.5, 5.0) 5.7 (1.)
200 mg Day 0 3 414.7 (63.0) 1448 (30.1) 1.0 (0.5, 3.0) 5.1 (0.6)
Day 15 0 NA NA NA NA